Bosh sahifaJNJ • ETR
add
Johnson & Johnson
Yopilish kursi
147,68 €
Kunlik diapazon
147,14 € - 148,42 €
Yillik diapazon
132,78 € - 154,00 €
Bozor kapitalizatsiyasi
385,53 mlrd USD
Oʻrtacha hajm
2,23 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NYSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(USD) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Daromad | 22,47 mlrd | 5,25% |
Joriy xarajat | 10,20 mlrd | 18,80% |
Sof foyda | 2,69 mlrd | -89,65% |
Sof foyda marjasi | 11,99 | -90,16% |
Har bir ulushga tushum | 2,42 | -9,02% |
EBITDA | 7,36 mlrd | -10,41% |
Amaldagi soliq stavkasi | 19,29% | — |
Balans
Jami aktivlari
Jami passivlari
(USD) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 20,30 mlrd | -13,67% |
Jami aktivlari | 178,29 mlrd | 7,36% |
Jami passivlari | 108,13 mlrd | 14,02% |
Umumiy kapital | 70,16 mlrd | — |
Tarqatilgan aksiyalar | 2,41 mlrd | — |
Narxi/balansdagi bahosi | 5,07 | — |
Aktivlardan daromad | 7,66% | — |
Kapitaldan daromad | 12,58% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
(USD) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Sof foyda | 2,69 mlrd | -89,65% |
Operatsiyalardan naqd pul | 7,99 mlrd | — |
Sarmoyadan naqd pul | -3,13 mlrd | — |
Moliyadan naqd pul | -9,88 mlrd | — |
Naqd pulning sof oʻzgarishi | -4,90 mlrd | — |
Boʻsh pul | 5,50 mlrd | — |
Haqida
Johnson & Johnson is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 40 on the 2023 Fortune 500 list of the largest United States corporations. In 2023, the company was ranked 40th in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 130,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato.
Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings. In 2023, the company split-off its consumer healthcare business sector into a new publicly traded company, Kenvue. The company is exclusively focused on developing and producing pharmaceutical prescription drugs and medical device technologies.
Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA. Wikipedia
Tashkil etilgan
yan 1886
Sayt
Xodimlar soni
131 900